{"protocolSection": {"identificationModule": {"nctId": "NCT00610116", "orgStudyIdInfo": {"id": "C007-CL-106002"}, "organization": {"fullName": "Boston Scientific Corporation", "class": "INDUSTRY"}, "briefTitle": "Electronic Repositioning With Acuity and Easytrak Leads", "officialTitle": "Electronic Repositioning With Acuity and Easytrak Leads", "acronym": "ERACE"}, "statusModule": {"statusVerifiedDate": "2021-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-09", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2008-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-01-24", "studyFirstSubmitQcDate": "2008-02-06", "studyFirstPostDateStruct": {"date": "2008-02-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2021-01-21", "resultsFirstSubmitQcDate": "2021-01-21", "resultsFirstPostDateStruct": {"date": "2021-02-09", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-03-30", "lastUpdatePostDateStruct": {"date": "2021-04-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Boston Scientific Corporation", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Evaluate appropriate performance of Electronic Repositioning\u2122 (ER) in the clinical routine, cumulative incidence of phrenic nerve stimulation (PNS) \\& success rates of Electronic Repositioning (ER) to remove it, various incl. left ventricular pacing (LVP) thresholds and PNS", "detailedDescription": "Bipolar leads for left ventricular pacing (LVP) such as the newly available ACUITY\u2122 or the standard EASYTRAK\u2122 II and EASYTRAK\u2122 III leads from GUIDANT in combination with suitable devices for cardiac resynchronization therapy (CRT) allow for the non-invasive programming of different Left Ventricular Pacing (LVP) configurations. Hence, this Electronic Repositioning (ER) may help physicians to overcome problems in cardiac resynchronization therapy (CRT) such as ineffective biventricular pacing, high Left Ventricular Pacing (LVP) thresholds and phrenic nerve stimulation (PNS) without the need for an additional patient's operation to reposition LV leads. The ERACE study it a multi-center, prospective, non-randomized clinical study to document and evaluate appropriate performance of GUIDANT's Electronic Repositioning\u2122 in the clinical routine with respect to the following major aspects:\n\navoidance of PNS and low LVP thresholds (for low battery consumption and extended device longevity) in standard cardiac resynchronization therapy (CRT)"}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 305, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "LV lead electronically repositioning", "type": "OTHER", "description": "Single arm study", "interventionNames": ["Device: Electronic Repositioning"]}], "interventions": [{"type": "DEVICE", "name": "Electronic Repositioning", "description": "Change of pacing vectors for CRT pacing", "armGroupLabels": ["LV lead electronically repositioning"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Proportion of Patients Without the Occurrence of Cardiac Resynchronization Therapy (CRT)-Induced Phrenic Nerve Stimulation (PNS) Between Implant and First Regular Follow-up (FU)", "description": "The primary endpoint was the percentage of patients in whom PNS induced by Left Ventricular (LV) pacing could be avoided by electronic repositioning from implantation to first regular follow up (3-6 months postimplant). In this evaluation, prevention of PNS was defined as PNS appearing with the standard pacing configuration-LV tip as cathode versus Right Ventricle (RV) coil as anode-and being avoided by at least one of the three alternative reprogrammable configurations.", "timeFrame": "From implant until first follow up (occurred between 3 or 6 month after implant procedure)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients receiving their FIRST implantation of a Left Ventricular (LV) lead in combination with a CRT device with implantable cardioverter defibrillator (ICD) backup and the possibility for Electronic Repositioning\u2122\n* Patients willing (= signed written consent) and capable to participate in all procedures of the study\"\n\nExclusion Criteria:\n\n* Patients who will not be available for routine Follow up\n* 18 years old\n* Known pregnancy.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "University Hospital", "city": "D\u00fcsseldorf", "zip": "40225", "country": "Germany", "geoPoint": {"lat": 51.22172, "lon": 6.77616}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "LV Lead Electronically Repositioning", "description": "Single arm study: Electronic Repositioning: Change of pacing vectors for cardiac resynchronization therapy pacing"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "305"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Number of analyzable patients", "numSubjects": "292"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "13"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "LV Lead Electronically Repositioning", "description": "Single arm study\n\nElectronic Repositioning: Change of pacing vectors for Cardiac Resynchronization Therapy pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "292"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "292"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "65.5", "spread": "9.2"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "292"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "52"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "240"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Proportion of Patients Without the Occurrence of Cardiac Resynchronization Therapy (CRT)-Induced Phrenic Nerve Stimulation (PNS) Between Implant and First Regular Follow-up (FU)", "description": "The primary endpoint was the percentage of patients in whom PNS induced by Left Ventricular (LV) pacing could be avoided by electronic repositioning from implantation to first regular follow up (3-6 months postimplant). In this evaluation, prevention of PNS was defined as PNS appearing with the standard pacing configuration-LV tip as cathode versus Right Ventricle (RV) coil as anode-and being avoided by at least one of the three alternative reprogrammable configurations.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "From implant until first follow up (occurred between 3 or 6 month after implant procedure)", "groups": [{"id": "OG000", "title": "Inducible PNS @ Max Output 7V / 0.5 ms", "description": "Patients presenting PNS at implant and subsequent follow up (between 3 and 6 months after implant)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "292"}]}], "classes": [{"title": "Inducible PNS before Electronic Reprogramming", "categories": [{"measurements": [{"groupId": "OG000", "value": "94"}]}]}, {"title": "Remaining PNS after Electronic Reprogramming", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "6 months", "eventGroups": [{"id": "EG000", "title": "LV Lead Electronically Repositioning", "description": "Electronic Repositioning: Change of pacing vectors for CRT pacing", "deathsNumAffected": 10, "deathsNumAtRisk": 292, "seriousNumAffected": 40, "seriousNumAtRisk": 292, "otherNumAffected": 32, "otherNumAtRisk": 292}], "seriousEvents": [{"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 292}]}, {"term": "Multiple heart failure symptoms", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 292}]}, {"term": "Deep vein thrombosis (DVT)", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Death (no details)", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 292}]}, {"term": "Coronary Sinus Dissection", "organSystem": "Surgical and medical procedures", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Gastrointestinal disease", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Inappropriate pulse generator Shock", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 292}]}, {"term": "Increase of Pacing Threshold", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Ineffective Pulse Generator Shock", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Inguinal Hernia", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Lead Dislodgment", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 292}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Pocket hematoma", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Syncope - Non cardiovascular", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Thoracic discomfort", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Lead Replacement - Unknown reason", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Intervention for Coronary Artery Disease", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 292}]}, {"term": "Cardiac Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Death - Sepsis", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Death - Hemorrhage", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Death - Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 292}]}], "otherEvents": [{"term": "Elevated Defibrillation Threshold", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Elevated Pacing threshold", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 292}]}, {"term": "Extracardiac stimulation", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 292}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 292}]}, {"term": "Multiple heart failure symptoms", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Immunotheraphy", "organSystem": "Immune system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Atrial Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 292}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Bruising", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Cholecystomy", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Coronary sinus dissection", "organSystem": "Surgical and medical procedures", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Lead Dislodgment", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 292}]}, {"term": "Pacing system infection", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Pocket Hematoma", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 292}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Pulse Generator system issue", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 292}]}, {"term": "Lead - Procedure", "organSystem": "Surgical and medical procedures", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 292}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Joachim Winter, MD", "organization": "Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.", "email": "joachim.winter@uniklinik-duesseldorf.de", "phone": "+49 (0) 2118", "phoneExt": "1173"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}